Low CSF CD4/CD8+ T-cell proportions are associated with blood-CSF barrier dysfunction in limbic encephalitis.
Adult
Autoimmune Diseases
/ cerebrospinal fluid
Biomarkers
/ cerebrospinal fluid
Blood-Brain Barrier
/ diagnostic imaging
CD4-Positive T-Lymphocytes
/ metabolism
CD8-Positive T-Lymphocytes
/ metabolism
Electroencephalography
/ methods
Epilepsy, Temporal Lobe
/ cerebrospinal fluid
Female
Humans
Limbic Encephalitis
/ cerebrospinal fluid
Magnetic Resonance Imaging
/ methods
Male
Middle Aged
Neuropsychological Tests
Young Adult
Autoimmunity
B-cells
Blood–CSF barrier
Limbic encephalitis
T-cells
Temporal lobe epilepsy
Journal
Epilepsy & behavior : E&B
ISSN: 1525-5069
Titre abrégé: Epilepsy Behav
Pays: United States
ID NLM: 100892858
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
received:
20
07
2019
revised:
10
10
2019
accepted:
02
11
2019
pubmed:
18
12
2019
medline:
27
10
2020
entrez:
18
12
2019
Statut:
ppublish
Résumé
Investigating immune cells in autoimmune limbic encephalitis (LE) will contribute to our understanding of its pathophysiology and may help to develop appropriate therapies. The aim of the present study was to analyze immune cells to reveal underlying immune signatures in patients with temporal lobe epilepsy (TLE) with LE. We investigated 68 patients with TLE with LE compared with 7 control patients with TLE with no signs of LE screened from 154 patients with suspected LE. From the patients with TLE-LE, we differentiated early seizure onset (<20 years, n = 9) and late seizure onset group (≥20 years, n = 59) of patients. Patients underwent neuropsychological assessment, electroencephalography (EEG), brain magnetic resonance imaging (MRI), and peripheral blood (PB) and cerebrospinal fluid (CSF) analysis including flow cytometry. We identified a higher CD4/8+ T-cell ratio in the PB in all patients with TLE-LE and in patients with late-onset TLE-LE each compared with controls (Kruskal-Wallis one-way ANOVA (analysis of variance) with Dunn's test, p < 0.05). Moreover, a lower CD4/CD8+ T-cell ratio is detected in all patients with TLE-LE with blood-CSF barrier dysfunction, unlike in those with none (Kruskal-Wallis one-way ANOVA with Dunn's test, p < 0.05). These findings suggest that the proportion of CD4+ and CD8+ T-cells in the CSF of patients with LE associated with blood-CSF barrier dysfunction plays a potential role in CNS (central nervous system) inflammation in these patients. Thus, flow cytometry as a methodology reveals novel insights into LE's genesis and symptomatology. The CD4/8+ T-cell ratio in PB as a biomarker for LE requires further investigation.
Identifiants
pubmed: 31846897
pii: S1525-5050(19)30696-1
doi: 10.1016/j.yebeh.2019.106682
pii:
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
106682Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.